Novel mutations of the MET proto-oncogene in papillary renal carcinomas

Oncogene

Volumn 18, Issue 14, 1999, Pages 2343-2350

  Schmidt, Laura ^a,b   Junker, Kerstin ^j   Nakaigawa, Noboru ^b   Kinjerski, Tracy ^a   Weirich, Gregor ^b   Miller, Maria ^b   Lubensky, Irina ^c   Neumann, Hartmut Ph ^d   Brauch, Hiltrud ^e   Decker, Johann ^f   Vocke, Cathy ^c   Brown, James A ^k   Jenkins, Robert ^g   Richard, Stephane ⁱ   Bergerheim, Ulf ^h   Gerrard, Bernard ^a   Dean, Michael ^b   Linehan, W Marston ^c   Zbar, Berton ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g MAYO CLINIC   (United States)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ BICÊTRE HOSPITAL   (France)

^j FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^k DAVID GRANT MEDICAL CENTER   (United States)

more..

Author keywords

MET protooncogene mutations; Papillary renal carcinoma; Receptor tyrosine kinase

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; DNA TRANSFECTION; GENE MUTATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MOLECULAR MODEL; MOUSE; MUTATION RATE; NONHUMAN; ONCOGENE MET; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTO ONCOGENE; SOLID TUMOR;

ANIMALIA;

EID: 0033535530     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202547     Document Type: Article

References (37)

1. Berndt I, Reuter M, Saller B, Frank-Raue K, Groth P, Grubendorf F, Raue F, Ritter MM and Hoppner W. (1998). J. Clin. Endo. Metab., 83, 770-774.
2. Borden EC, Hogan TF and Voelkel JG. (1982). Cancer Res., 42, 4948-4953.
3. Brown JA, Anderl KL, Borell TJ, Qian J, Bostwick DJ and Jenkins RB. (1997). J. Urology, 158, 370-374.
4. Di Renzo MF, Olivero M, Serini G, Orlandi F, Pilotti S, Belfiore A, Costantino A, Vigneri R, Angeli A, Pierotti MA and Comoglio PM. (1995). J. Endocrinol. Invest., 18, 134-139.
5. Duh F-M, Scherer SW, Tsui L-C, Lerman M, Zbar B and Schmidt L. (1997). Oncogene, 15, 1583-1586.
6. Ermis A, Henn W, Remberger K, Hopf C, Hopf T and Zang KD. (1995). Human Genet., 96, 651-654.
7. Fattoruso O, Quadro L, Libroia A, Verga U, Lupoli G, Cascone E and Colantuoni V. (1998). Human Mutation Supplement, 1, S167-S171.
8. Fischer J, Palmedo G and Kovacs G. (1998). Proc. Amer. Assoc. Can. Res., 39, 130.
9. Grignon DJ and Eble JN. (1998). Semin. Diagnos. Pathol., 15, 41-53.
10. Hanafusa H. (1986). In: Oncogenes and Growth Control. Kahn P and Graf T. (ed.). Springer-Verlag: Berlin, Heidelberg, pp. 100-105.
11. Huang H, Qian C, Jenkins RB and Smith DI. (1998). Genes, Chromosomes and Cancer, 21, 152-159.
12. Hubbard SR, Wei L, Ellis L and Hendrikson WA. (1994). Nature, 372, 746-754.
13. Hubbard SR. (1997). EMBO J., 16, 5572-5581.
14. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B and Vande Woude GF. (1997). Proc. Natl. Acad. Sci. USA, 94, 11445-11450.
15. Jeffers M, Rong S and Vande Woude GF. (1996). J. Mol. Med., 74, 505-513.
16. Kovacs G. (1993). Adv. Cancer Res., 62, 89-124.
17. Levy JB, Iba H and Hanafusa H. (1986). Proc. Natl. Acad. Sci. USA, 83, 4228-4232.
18. Lin JC, Scherer SW, Tougar L, Traverso G, Tsui L-C, Andrulis IL, Jothy S and Park M. (1996). Oncogene, 13, 2001-2008.
19. Park M, Dean M, Kaul K, Braun MJ, Gonda MA and Vande Woude GF. (1987). Proc. Nat. Acad. Sci. USA, 84, 6379-6383.
20. Pignon J-M. (1997). Hematol. Cell Ther., 39, 114-116.
21. Santoro MM, Penengo L, Minetto M, Orecchia S, Cili M and Gaudino G. (1998). Oncogene, 17, 741-749.
22. Schmidt L, Li F, Brown RS, Berg S, Chen F, Wei M-W, Tory K, Lerman MI and Zbar B. (1995). Cancer J. Sci. Amer., 1, 191-196.
23. Schmidt L, Duh F-M, Chen F, Kishida T, Glenn G, Choyke P, Scherer S, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui L-C, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM and Zbar B. (1997). Nature Genet., 16, 68-73.
24. Schmidt L, Li H, Wei M-H, Lerman MI, Zbar B and Tory K. (1993). Human Mol. Genet., 2, 817-818.
25. Schmidt L, Junker K, Weirich G, Glenn G, Choyke P, Lubensky I, Zhuang Z, Jeffers M, Vande Woude G, Neumann H, Walther M, Linehan WM and Zbar B. (1998). Cancer Res., 58, 1719-1722.
26. Shu H-K, Pelley RJ and Kung H-J. (1990). Proc. Natl. Acad. Sci. USA, 87, 9103-9107.
27. Shu H-K, Pelley RJ and Kung HJ. (1991). Virology, 65, 6173-6180.
28. Shu H-K, Chang C-M, Lakshmeswari R, Ling L, Castellano CH, Walterm E, Pelley RJ and Kung H-J. (1994). Mol. Cell Biol., 14, 6868-6878.
29. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwillian R, Ross M, Linehan WM, Birdsall S, Shipley J and Cooper CS. (1996). Hum. Mol. Genet., 5, 1333-1338.
30. Weterman MA, Wilbrink M and van Kessel AG. (1996). Proc. Natl. Acad. Sci. USA, 93, 15294-15298.
31. Ullrich A and Schlessinger J. (1990). Cell, 61, 203-212.
32. Underhill PA, Jin L, Zemano R, Oefner PJ and Cavalli-Sforza LL. (1996). Proc. Natl. Acad. Sci. USA, 93, 196-200.
33. Zbar B, Tory K, Merino M, Schmidt L, Glenn G, Choyke P, Walther MM and Linehan WM. (1994). J. Urol., 15, 561-566.
34. Zbar B and Lerman M. (1998). Adv. Cancer Res., 75, 163-201.
35. Zenklusen JC, Thompson JC, Troncoso P, Kagan J and Conti CJ. (1994). Cancer Res., 54, 6370-6373.
36. Zenklusen JC, Weitzel JN, Ball HG and Conti JC. (1995). Oncogene, 11, 359-363.
37. Zhuang Z, Park WS, Pack S, Schmidt L, Vortmeyer AO, Pak E, Pham T, Candidas S, Weil RJ, Lubensky I, Linehan WM, Zbar B and Weirich G. (1998). Nature Gen., 20, 66-69.